Abstract
Background: Elizabethkingia meningoseptica is a ubiquitous organism rarely associated with human diseases, but its association especially among hospitalized premature neonates and immunocompromised individuals are not so common.
Case: We report two cases of neonatal bacteraemia and meningitis among low birth weight premature neonates admitted in neonatal intensive care units (NICU) by E. meningoseptica, a high alert organism associated with such conditions.
Conclusions: E. meningoseptica, a high alert organism associated with meningitis among premature underweight neonates. High degree of resistant to most of the broad-spectrum antibiotics makes its management a challenging task. A good communication between the clinician and the microbiologist becomes very important for the proper management of the patients.
Keywords: Elizabethkingia meningoseptica, neonatal meningitis, bacteraemia, NICU, pneumonia, ICUs.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:Case Series and Mini-Review on Elizabethkingia meningoseptica, A high Alert Organism Causing Meningitis in Premature Neonates from A Tertiary Care Hospital of Western Rajasthan
Volume: 21 Issue: 8
Author(s): Kumar S Abhishek, Sarika P. Kombade*, Neeraj Gupta, Vibhor Tak, Vijaya Lakshmi Nag, Kuldeep Singh and Nidhima Agarwal
Affiliation:
- Department of Microbiology, AIIMS, Basni phase 2, Jodhpur, Rajasthan,India
Keywords: Elizabethkingia meningoseptica, neonatal meningitis, bacteraemia, NICU, pneumonia, ICUs.
Abstract: Background: Elizabethkingia meningoseptica is a ubiquitous organism rarely associated with human diseases, but its association especially among hospitalized premature neonates and immunocompromised individuals are not so common.
Case: We report two cases of neonatal bacteraemia and meningitis among low birth weight premature neonates admitted in neonatal intensive care units (NICU) by E. meningoseptica, a high alert organism associated with such conditions.
Conclusions: E. meningoseptica, a high alert organism associated with meningitis among premature underweight neonates. High degree of resistant to most of the broad-spectrum antibiotics makes its management a challenging task. A good communication between the clinician and the microbiologist becomes very important for the proper management of the patients.
Export Options
About this article
Cite this article as:
Abhishek S Kumar , Kombade P. Sarika *, Gupta Neeraj , Tak Vibhor , Nag Lakshmi Vijaya , Singh Kuldeep and Agarwal Nidhima, Case Series and Mini-Review on Elizabethkingia meningoseptica, A high Alert Organism Causing Meningitis in Premature Neonates from A Tertiary Care Hospital of Western Rajasthan, Infectious Disorders - Drug Targets 2021; 21 (8) : e160921189884 . https://dx.doi.org/10.2174/1871526520666210104151430
DOI https://dx.doi.org/10.2174/1871526520666210104151430 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In-Vivo Gene Delivery by Sonoporation: Recent Progress and Prospects
Current Gene Therapy Quorum Sensing and Biofilms in the Pathogen, Streptococcus pneumoniae
Current Pharmaceutical Design Tuberculosis - Present Medication and Therapeutic Prospects
Current Medicinal Chemistry Pharmaceutical Counterfeiting and Analytical Authentication
Current Pharmaceutical Analysis Psychosocial Stress, Emotions and Cytokine-Related Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis
Current Pharmaceutical Design The Multi-faceted Profile of Corticotropin-releasing Factor (CRF) Family of Neuropeptides and of their Receptors on the Paracrine/Local Regulation of the Inflammatory Response
Current Molecular Pharmacology Radiolabeled Organism-Specific Antibodies for Diagnosis and Therapy of Infections
Current Medical Imaging Inhaled Dry Powder Formulations for Treating Tuberculosis
Current Drug Delivery Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
Current Drug Safety Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision
Anti-Cancer Agents in Medicinal Chemistry Advances in Metabonomics on Infectious Diseases
Current Metabolomics Microscopies at the Nanoscale for Nano-Scale Drug Delivery Systems
Current Drug Targets Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Current Neuropharmacology Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status
Current Drug Targets - CNS & Neurological Disorders Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design The Pathology Induced by Highly Active Antiretroviral Therapy Against Human Immunodeficiency Virus: an Update
Current Medicinal Chemistry Analysis of Adverse Events Related to 720 Cases of Neural Progenitor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer
Current Cancer Drug Targets Understanding the Use of Immunosuppressive Agents in the Clinical Management of IBD
Current Drug Targets